Acute hcv/hiv coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Garvey, Lucy J ^a,b   Pavese, Nicola ^a   Ramlackhansingh, Anil ^a   Thomson, Emma ^a,b   Allsop, Joanna M ^a   Politis, Marios ^a   Kulasegaram, Ranjababu ^c   Main, Janice ^a,b   Brooks, David J ^a   Taylor Robinson, Simon D ^a   Winston, Alan ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CREATININE; INOSITOL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; VIRUS RNA;

ACUTE DISEASE; ADULT; ARTICLE; BASAL GANGLION; BINDING AFFINITY; BRAIN DYSFUNCTION; BRAIN FUNCTION; CASE CONTROL STUDY; CELL ACTIVATION; CEREBRAL METABOLITE DISTURBANCE; CHRONIC DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRONTAL LOBE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MICROGLIA; MIXED INFECTION; NEUROLOGIC EXAMINATION; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE;

ACUTE DISEASE; ADULT; BIOLOGICAL TRANSPORT; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CHRONIC DISEASE; COGNITION; COINFECTION; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; ISOQUINOLINES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROGLIA; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 84863743741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038980     Document Type: Article

References (44)

1. Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, et al. (2005) Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retroviruses 21: 706-713.
2. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, et al. (2001) Evidence for a cerebral effect of the hepatitis C virus. Lancet 358: 38-39.
3. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, et al. (2002) Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35: 433-439.
4. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, et al. (1996) Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study. Neurology 46: 783-788.
5. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, et al. (2004) Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41: 845-851.
6. Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P, (2004) Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 62: 957-962.
7. Richardson JL, Nowicki M, Danley K, Martin EM, Cohen MH, et al. (2005) Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women. Aids 19: 1659-1667.
8. Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, et al. (2005) The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. Aids 19: S72-78.
9. Murray J, Fishman SL, Ryan E, Eng FJ, Walewski JL, et al. (2008) Clinicopathologic correlates of hepatitis C virus in brain: a pilot study. J Neurovirol 14: 17-27.
10. Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, et al. (2002) Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 76: 10064-10068.
11. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC, (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 78: 5170-5183.
12. Gonzalez-Scarano F, Baltuch G, (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22: 219-240.
13. Forton DM, Allsop JM, Cox IJ, Hamilton G, Wesnes K, et al. (2005) A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. Aids 19: S53-63.
14. Rojas S, Martin A, Arranz MJ, Pareto D, Purroy J, et al. (2007) Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab 27: 1975-1986.
15. Shah F, Hume SP, Pike VW, Ashworth S, McDermott J, (1994) Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol 21: 573-581.
16. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, et al. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 (Pt 11): 2321-2337.
17. Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, et al. (2007) Imaging microglial activation in Huntington's disease. Brain Res Bull 72: 148-151.
18. Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, et al. (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 21: 404-412.
19. Cagnin A, Taylor-Robinson SD, Forton DM, Banati RB, (2006) In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut 55: 547-553.
20. Grover VPB PN, Koh SB, Wylezinska M, et al. (2012) Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepatol 19: 89-96.
21. Hammoud DA, Endres CJ, Chander AR, Guilarte TR, Wong DF, et al. (2005) Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS. J Neurovirol 11: 346-355.
22. Wiley CA, Lopresti BJ, Becker JT, Boada F, Lopez OL, et al. (2006) Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment. J Neurovirol 12: 262-271.
23. Browne R, Asboe D, Gilleece Y, Atkins M, Mandalia S, et al. (2004) Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? Sex Transm Infect 80: 326-327.
24. Ghosn J, Pierre-Francois S, Thibault V, Duvivier C, Tubiana R, et al. (2004) Acute hepatitis C in HIV-infected men who have sex with men. HIV Med 5: 303-306.
25. Winston A, Garvey L, Scotney E, Yerrakalva D, Allsop JM, et al. (2010) Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals? J Viral Hepat 17: 419-426.
26. Cysique LA, Maruff P, Darby D, Brew BJ, (2006) The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol 21: 185-194.
27. Winston A, Duncombe C, Li PC, Gill JM, Kerr SJ, et al. (2010) Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Clin Infect Dis 50: 920-929.
28. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, et al. (2001) Java-based graphical user interface for the MRUI quantitation package. MAGMA 12: 141-152.
29. Kanowski M, Kaufmann J, Braun J, Bernarding J, Tempelmann C, (2004) Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magn Reson Med 51: 904-912.
30. Lammertsma AA, Hume SP, (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4: 153-158.
31. Turkheimer FE, Edison P, Pavese N, Roncaroli F, Anderson AN, et al. (2007) Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med 48: 158-167.
32. Morgello S, Estanislao L, Ryan E, Gerits P, Simpson D, et al. (2005) Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals. Aids 19: S116-122.
33. Ridderinkhof KR, Ullsperger M, Crone EA, Nieuwenhuis S, (2004) The role of the medial frontal cortex in cognitive control. Science 306: 443-447.
34. Melrose RJ, Tinaz S, Castelo JM, Courtney MG, Stern CE, (2008) Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav Brain Res 188: 337-347.
35. Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S, (2000) Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 32: 1035-1038.
36. Forton DM, Hamilton G, Allsop JM, Grover VP, Wesnes K, et al. (2008) Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol 49: 316-322.
37. Kim SJ, Kim IJ, Kim YK, Lee TH, Lee JS, Jun S, et al. (2008) Probabilistic anatomic mapping of cerebral blood flow distribution of the middle cerebral artery. J Nucl Med 49: 39-43.
38. Chaudhuri A, Behan PO, (2004) Fatigue in neurological disorders. Lancet 363: 978-988.
39. Malm TM, Koistinaho M, Parepalo M, Vatanen T, Ooka A, et al. (2005) Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 18: 134-142.
40. Brown AK, Fujita M, Fujimura Y, Liow JS, Stabin M,et al. Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation (2007) J Nucl Med 48: 2072-2079.
41. Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, et al. (2009) Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans. J Nucl Med 50: 1276-1282.
42. Venneti S, Wang G, Nguyen J, Wiley CA, (2008) The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders. J Neuropathol Exp Neurol 67: 1001-1010.
43. Christensen JD, Kaufman MJ, Levin JM, Mendelson JH, Holman BL, et al. (1996) Abnormal cerebral metabolism in polydrug abusers during early withdrawal: a 31P MR spectroscopy study. Magn Reson Med 35: 658-663.
44. Vogel M, Dominguez S, Bhagani S, Azwa A, Page E, et al. (2010) Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort. Antivir Ther 15: 267-279.